Search Results - Manu De Rycker

Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay. by Nina Svensen, Susan Wyllie, David W Gray, Manu De Rycker

Connect to this object online.

A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes. by Manu De Rycker, Sandra O'Neill, Dhananjay Joshi, Lorna Campbell, David W Gray, Alan H Fairlamb

Connect to this object online.

Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade. by Manu De Rycker, John Thomas, Jennifer Riley, Stephen J Brough, Tim J Miles, David W Gray

Connect to this object online.

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery. by Lorna M MacLean, John Thomas, Michael D Lewis, Ignacio Cotillo, David W Gray, Manu De Rycker

Connect to this object online.

Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intrac... by Andrea Nühs, Manu De Rycker, Sujatha Manthri, Eamon Comer, Christina A Scherer, Stuart L Schreiber, Jean-Robert Ioset, David W Gray

Connect to this object online.

Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity. by Maikel Izquierdo, De Lin, Sandra O'Neill, Lauren A Webster, Christy Paterson, John Thomas, Mirtha Elisa Aguado, Enrique Colina Araújo, Daniel Alpízar-Pedraza, Halimatu Joji, Lorna MacLean, Anthony Hope, David W Gray, Martin Zoltner, Mark C Field, Jorge González-Bacerio, Manu De Rycker

Connect to this object online.